Frailty, Revascularization and Quality of Life: A New Look at BEST-CLI #ActAgainstAmputation diabeticfootonline.c...
November 7, 2026 at 12:47 AM
Frailty, Revascularization and Quality of Life: A New Look at BEST-CLI #ActAgainstAmputation diabeticfootonline.c...
A positive cardiac composite can hide a weak result. If death, MI, and revascularization are bundled, the headline may be driven by revascularization, the component most open to clinical judgment. Report each component, not just the composite.
November 7, 2026 at 6:38 PM
A positive cardiac composite can hide a weak result. If death, MI, and revascularization are bundled, the headline may be driven by revascularization, the component most open to clinical judgment. Report each component, not just the composite.
Frailty, Revascularization and Quality of Life: A New Look at BEST-CLI #ActAgainstAmputation
A new BEST-CLI conference abstract reports quality-of-life improvement after revascularization in selected patients with frailty. What the findings mean for patient-centered limb preservation, and what…
A new BEST-CLI conference abstract reports quality-of-life improvement after revascularization in selected patients with frailty. What the findings mean for patient-centered limb preservation, and what…
Frailty, Revascularization and Quality of Life: A New Look at BEST-CLI #ActAgainstAmputation
A new BEST-CLI conference abstract reports quality-of-life improvement after revascularization in selected patients with frailty. What the findings mean for patient-centered limb preservation, and what they cannot yet tell us.
diabeticfootonline.com
November 6, 2026 at 6:55 PM
Frailty, Revascularization and Quality of Life: A New Look at BEST-CLI #ActAgainstAmputation
A new BEST-CLI conference abstract reports quality-of-life improvement after revascularization in selected patients with frailty. What the findings mean for patient-centered limb preservation, and what…
A new BEST-CLI conference abstract reports quality-of-life improvement after revascularization in selected patients with frailty. What the findings mean for patient-centered limb preservation, and what…
New Study Confirms CAAS-vFFR Revascularization Matches Pressure Wire Methods#Netherlands#Maastricht#Pie_Medical_Imaging#CAAS-vFFR#Revascularization
New Study Confirms CAAS-vFFR Revascularization Matches Pressure Wire Methods
The LIPSIA-STRATEGY study reveals CAAS-vFFR guided revascularization is as effective as traditional pressure wire methods, benefiting both patients and practitioners.
third-news.com
November 3, 2026 at 11:30 AM
New Study Confirms CAAS-vFFR Revascularization Matches Pressure Wire Methods#Netherlands#Maastricht#Pie_Medical_Imaging#CAAS-vFFR#Revascularization
New Findings from LIPSIA-STRATEGY Trial Reinforce CAAS vFFR as a Safe Revascularization Method#Netherlands#Maastricht#CAAS_vFFR#Pie_Medical_Imaging#Revascularization
New Findings from LIPSIA-STRATEGY Trial Reinforce CAAS vFFR as a Safe Revascularization Method
The LIPSIA-STRATEGY trial demonstrates that revascularization guided by CAAS vFFR is as effective as traditional methods, providing a less invasive option for patients.
third-news.com
November 3, 2026 at 11:31 AM
New Findings from LIPSIA-STRATEGY Trial Reinforce CAAS vFFR as a Safe Revascularization Method#Netherlands#Maastricht#CAAS_vFFR#Pie_Medical_Imaging#Revascularization
PCI in TAVI candidates with coronary artery disease: impact of revascularization strategy and timing on outcomes #recintervcardiol #Aheadofprint https://doi.org/10.24875/RECICE.M26000617
November 6, 2026 at 5:00 PM
PCI in TAVI candidates with coronary artery disease: impact of revascularization strategy and timing on outcomes #recintervcardiol #Aheadofprint https://doi.org/10.24875/RECICE.M26000617
Pie Medical Imaging's LIPSIA-STRATEGY Trial Presents Significant Findings in Revascularization Techniques#Netherlands#Maastricht#CAAS_vFFR#LIPSIA-STRATEGY#Pie_Medical
Pie Medical Imaging's LIPSIA-STRATEGY Trial Presents Significant Findings in Revascularization Techniques
Pie Medical Imaging announces the results of the LIPSIA-STRATEGY trial, showcasing CAAS vFFR's effectiveness in coronary revascularization compared to traditional methods.
third-news.com
November 3, 2026 at 11:30 AM
Pie Medical Imaging's LIPSIA-STRATEGY Trial Presents Significant Findings in Revascularization Techniques#Netherlands#Maastricht#CAAS_vFFR#LIPSIA-STRATEGY#Pie_Medical
Angiography-derived vFFR-guided revascularization met the prespecified absolute criterion for noninferiority to wire-based FFR, according to results from the LIPSIA-STRATEGY trial presented at #TCT2026 and simultaneously published in #JACC. 🔗 https://bit.ly/4szDdNj
@crfheart.bsky.social
@crfheart.bsky.social
November 2, 2026 at 11:55 PM
Angiography-derived vFFR-guided revascularization met the prespecified absolute criterion for noninferiority to wire-based FFR, according to results from the LIPSIA-STRATEGY trial presented at #TCT2026 and simultaneously published in #JACC. 🔗 https://bit.ly/4szDdNj
@crfheart.bsky.social
@crfheart.bsky.social
LIPSIA-STRATEGY Trial Validates CAAS vFFR as a Safe Alternative to Pressure Wire Revascularization#Netherlands#Maastricht#CAAS_vFFR#Pie_Medical_Imaging#LIPSIA-STRATEGY
LIPSIA-STRATEGY Trial Validates CAAS vFFR as a Safe Alternative to Pressure Wire Revascularization
The LIPSIA-STRATEGY trial confirms that angiography-based CAAS vFFR guided revascularization is as effective as wire-based methods, enhancing patient safety and procedure efficiency.
third-news.com
November 3, 2026 at 11:30 AM
LIPSIA-STRATEGY Trial Validates CAAS vFFR as a Safe Alternative to Pressure Wire Revascularization#Netherlands#Maastricht#CAAS_vFFR#Pie_Medical_Imaging#LIPSIA-STRATEGY
Groundbreaking Results from LIPSIA-STRATEGY Trial Compare CAAS vFFR and Pressure Wire-Based Revascularization Techniques#Netherlands#Maastricht#CAAS_vFFR#Pie_Medical_Imaging#LIPSIA-STRATEGY
Groundbreaking Results from LIPSIA-STRATEGY Trial Compare CAAS vFFR and Pressure Wire-Based Revascularization Techniques
The LIPSIA-STRATEGY trial marks a significant advancement in revascularization techniques, showing that CAAS vFFR guidance offers similar outcomes to pressure wire methods.
third-news.com
November 3, 2026 at 11:30 AM
Groundbreaking Results from LIPSIA-STRATEGY Trial Compare CAAS vFFR and Pressure Wire-Based Revascularization Techniques#Netherlands#Maastricht#CAAS_vFFR#Pie_Medical_Imaging#LIPSIA-STRATEGY
The ISCHEMIA Trial a Decade Later jamanetwork.com/journals/jam...
The ISCHEMIA Trial a Decade Later
Whether an initial revascularization strategy improves outcomes compared with optimal medical therapy in patients with chronic stable coronary artery disease has been a question of considerable clinic...
jamanetwork.com
November 7, 2026 at 7:41 PM
The ISCHEMIA Trial a Decade Later jamanetwork.com/journals/jam...
Open Access UCL Research: Retrograde access revascularization in chronic limb threatening ischaemia
discovery.ucl.ac.uk/id/eprint/10...
discovery.ucl.ac.uk/id/eprint/10...
November 2, 2026 at 10:06 AM
Open Access UCL Research: Retrograde access revascularization in chronic limb threatening ischaemia
discovery.ucl.ac.uk/id/eprint/10...
discovery.ucl.ac.uk/id/eprint/10...
SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopliteal Disease
Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with…
Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with…
SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopliteal Disease
Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with MagicTouch PTA, with similar walking capacity, quality of life…
news-area.com
November 3, 2026 at 11:59 PM
SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopliteal Disease
Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with…
Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with…
Mortality Similar With PCI, CABG in Left Main CAD in a Broad Asian Population
Mortality Similar With PCI, CABG in Left Main CAD in a Broad Asian Population
Mortality Similar With PCI, CABG in Left Main CAD in a Broad Asian Population
mosbey@crf.org
Tue, 11/03/2026 - 19:57
Todd Neale
The IRIS-MAIN registry results did show some differences in nonfatal outcomes like stroke, MI, and revascularization.
www.tctmd.com
November 4, 2026 at 1:11 AM
Mortality Similar With PCI, CABG in Left Main CAD in a Broad Asian Population
From the latest issue: Yahyavi & colleagues compare CREST-2 participants with patients undergoing carotid revascularization in real-world practice, finding substantial alignment in baseline characteristics and GDMT-related measures, supporting the generalizability of CREST-2.
doi.org/10.1177/1358...
doi.org/10.1177/1358...
Generalizability of the CREST‑2 trial: A real‑world analysis - Ashkan Yahyavi, Mehdi H Shishehbor, 2026
Alternatively, explore:
doi.org
November 6, 2026 at 5:01 PM
From the latest issue: Yahyavi & colleagues compare CREST-2 participants with patients undergoing carotid revascularization in real-world practice, finding substantial alignment in baseline characteristics and GDMT-related measures, supporting the generalizability of CREST-2.
doi.org/10.1177/1358...
doi.org/10.1177/1358...
Three-Year Outcomes of the SIRONA Study Highlight Benefits of Sirolimus-Coated Balloons#USA#Tampa#Concept_Medical#Sirolimus_Balloons#SIRONA_Study
Three-Year Outcomes of the SIRONA Study Highlight Benefits of Sirolimus-Coated Balloons
The three-year results of the SIRONA study reveal that patients treated with sirolimus-coated balloons experience improved outcomes compared to those with paclitaxel-coated balloons, particularly in revascularization rates.
third-news.com
November 4, 2026 at 6:50 AM
Three-Year Outcomes of the SIRONA Study Highlight Benefits of Sirolimus-Coated Balloons#USA#Tampa#Concept_Medical#Sirolimus_Balloons#SIRONA_Study
SIRONA Trial Three-Year Results: Sirolimus-Coated Balloons Offer Improved Outcomes in Femoropopliteal Disease#USA#Tampa#SIRONA_Trial#Sirolimus_Balloon#Femoropopliteal_Disease
SIRONA Trial Three-Year Results: Sirolimus-Coated Balloons Offer Improved Outcomes in Femoropopliteal Disease
New findings from the SIRONA trial reveal that sirolimus-coated balloons significantly reduce the need for further revascularization procedures compared to paclitaxel-coated balloons in patients.
third-news.com
November 3, 2026 at 10:34 AM
SIRONA Trial Three-Year Results: Sirolimus-Coated Balloons Offer Improved Outcomes in Femoropopliteal Disease#USA#Tampa#SIRONA_Trial#Sirolimus_Balloon#Femoropopliteal_Disease
In a randomized trial, CCTA-guided PCI with structured preprocedural planning and intraprocedural guidance was noninferior to intravascular ultrasound–guided PCI with respect to target-vessel failure at 12 months. Full P4 trial results: https://nej.md/48jfVly
#TCT2026 | @crfheart.bsky.social
#TCT2026 | @crfheart.bsky.social
November 1, 2026 at 6:50 PM
In a randomized trial, CCTA-guided PCI with structured preprocedural planning and intraprocedural guidance was noninferior to intravascular ultrasound–guided PCI with respect to target-vessel failure at 12 months. Full P4 trial results: https://nej.md/48jfVly
#TCT2026 | @crfheart.bsky.social
#TCT2026 | @crfheart.bsky.social
🧵 In patients with severe asymptomatic #carotid artery stenosis, carotid revascularization with carotid artery stenting or carotid endarterectomy plus intensive medical management did not improve cognition vs intensive medical management alone over up to 4 years.
ja.ma/4eU9CIM
ja.ma/4eU9CIM
October 27, 2026 at 4:54 PM
🧵 In patients with severe asymptomatic #carotid artery stenosis, carotid revascularization with carotid artery stenting or carotid endarterectomy plus intensive medical management did not improve cognition vs intensive medical management alone over up to 4 years.
ja.ma/4eU9CIM
ja.ma/4eU9CIM
🧵 Among patients with asymptomatic high-grade internal #carotid artery stenosis and reduced cognition at baseline, carotid revascularization plus intensive medical management did not improve cognitive outcomes vs intensive medical management alone over 1 year.
ja.ma/4zcuCCN
ja.ma/4zcuCCN
October 27, 2026 at 4:48 PM
🧵 Among patients with asymptomatic high-grade internal #carotid artery stenosis and reduced cognition at baseline, carotid revascularization plus intensive medical management did not improve cognitive outcomes vs intensive medical management alone over 1 year.
ja.ma/4zcuCCN
ja.ma/4zcuCCN
📊 Research Summary: Baseline hemodynamic impairment did not identify a cognitive benefit of carotid revascularization in asymptomatic high-grade internal #carotid artery stenosis.
ja.ma/4zRfuL2
ja.ma/4zRfuL2
October 27, 2026 at 4:48 PM
📊 Research Summary: Baseline hemodynamic impairment did not identify a cognitive benefit of carotid revascularization in asymptomatic high-grade internal #carotid artery stenosis.
ja.ma/4zRfuL2
ja.ma/4zRfuL2
William A. Gray, MD, discusses how clinical evidence, anatomic suitability, operator experience, and patient preferences inform decisions about medical therapy and carotid revascularization. https://ow.ly/aABe5101JwU
October 28, 2026 at 4:15 PM
William A. Gray, MD, discusses how clinical evidence, anatomic suitability, operator experience, and patient preferences inform decisions about medical therapy and carotid revascularization. https://ow.ly/aABe5101JwU
💬 Editorial: In patients with asymptomatic #carotid artery stenosis, carotid revascularization did not improve cognition or prevent cognitive decline compared with medical therapy alone in the CREST-2 cognitive analyses.
ja.ma/4BpfVxX
ja.ma/4BpfVxX
October 27, 2026 at 4:54 PM
💬 Editorial: In patients with asymptomatic #carotid artery stenosis, carotid revascularization did not improve cognition or prevent cognitive decline compared with medical therapy alone in the CREST-2 cognitive analyses.
ja.ma/4BpfVxX
ja.ma/4BpfVxX